Skip to content

NANOVIRICIDES, INC.: 10-K filed 2015-09-14

What NANOVIRICIDES, INC. reported in its annual report filed 2015-09-14 (fiscal FY 2015): 32 published measures, 85 facts as tagged in accession 0001144204-15-054864.

This filing

Form
10-K (annual report)
Filed
2015-09-14
Fiscal period
fiscal FY 2015
Accession
0001144204-15-054864 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANOVIRICIDES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-3044,187,089USD
At 2014-06-3043,859,995USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-3012,401,222USD
At 2014-06-3020,490,692USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-3031,785,867USD
At 2014-06-3023,369,303USD
At 2013-06-308,009,652USD
At 2012-06-3013,850,192USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-3031,467,748USD
At 2014-06-3036,696,892USD
At 2013-06-3013,923,245USD
At 2012-06-3014,274,985USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2015-06-30-2,198,172USD365
2013-07-01 to 2014-06-30-13,601,616USD365
2012-07-01 to 2013-06-30-8,875,668USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-07-01 to 2015-06-306,760,109USD365
2013-07-01 to 2014-06-305,231,094USD365
2012-07-01 to 2013-06-3064,931USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-54,099,572USD
At 2014-06-30-51,901,400USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-07-01 to 2015-06-3056,553,848shares365
2013-07-01 to 2014-06-3051,225,622shares365
2012-07-01 to 2013-06-3045,892,549shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-01 to 2015-06-3059,220,515shares365
2013-07-01 to 2014-06-3051,225,622shares365
2012-07-01 to 2013-06-3047,606,835shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2015-06-30-0.04USD/shares365
2013-07-01 to 2014-06-30-0.27USD/shares365
2012-07-01 to 2013-06-30-0.19USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-07-01 to 2015-06-30-0.09USD/shares365
2013-07-01 to 2014-06-30-0.27USD/shares365
2012-07-01 to 2013-06-30-0.19USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2015-06-300USD365
2013-07-01 to 2014-06-300USD365
2012-07-01 to 2013-06-300USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-3011,962,648USD
At 2014-06-305,496,756USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2015-06-30-7,063,100USD365
2013-07-01 to 2014-06-30-8,667,372USD365
2012-07-01 to 2013-06-30-6,590,379USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-3031,682,173USD
At 2014-06-3036,954,981USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-07-01 to 2015-06-302,649,592USD365
2013-07-01 to 2014-06-303,092,550USD365
2012-07-01 to 2013-06-30962,535USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-30600,895USD
At 2014-06-30517,739USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2015-06-30399,737USD
At 2014-06-30408,258USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2015-06-307,063,100USD365
2013-07-01 to 2014-06-308,667,372USD365
2012-07-01 to 2013-06-306,590,379USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2015-06-303,660,322USD365
2013-07-01 to 2014-06-305,131,523USD365
2012-07-01 to 2013-06-304,292,909USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3057,242,070shares
At 2014-06-3054,620,993shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3085,824,613USD
At 2014-06-3075,212,888USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-06-3013,496,851USD
At 2014-06-306,736,742USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-06-301,534,203USD
At 2014-06-301,239,986USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2015-06-30399,737USD
At 2014-06-30408,258USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-3028,515USD
At 2014-06-3091,838USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2015-06-300USD
At 2014-06-300USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2015-06-30-2,198,172USD365
2013-07-01 to 2014-06-30-13,601,616USD365
2012-07-01 to 2013-06-30-8,875,668USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-07-01 to 2015-06-30-2,198,172USD365
2013-07-01 to 2014-06-30-13,601,616USD365
2012-07-01 to 2013-06-30-8,875,668USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2015-06-303,402,778USD365
2013-07-01 to 2014-06-303,535,849USD365
2012-07-01 to 2013-06-302,297,470USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-07-01 to 2015-06-30294,217USD365
2013-07-01 to 2014-06-30203,234USD365
2013-07-01 to 2014-03-31203,234USD274
2012-07-01 to 2013-06-30210,877USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2015-06-304,864,928USD365
2013-07-01 to 2014-06-30-4,934,244USD365
2012-07-01 to 2013-06-30-2,285,289USD365

Inspect the source

Entity
NANOVIRICIDES, INC. / CIK 0001379006
Captured
SEC response SHA-256
5d15adcbc42d7ac8bfebbf748da8ae31563dd5d02e790dc3e1b9bde076c805d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001379006.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))